Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES

Multiple Microbiological Tests Needed for Underweight Newborns

By Labmedica International staff writers
Posted on 04 Mar 2013
Image: The oral bacteria Fusobacterium nucleatum (Photo courtesy of HealthyDent).
Image: The oral bacteria Fusobacterium nucleatum (Photo courtesy of HealthyDent).
Cultures commonly used to detect bacterial infections in low birth-weight newborns with early onset sepsis may fail to detect some microorganisms.

There is a need for multiple detection methods, such as DNA genomic analyses and other independent culture technologies, to identify bacteria that routine culturing may miss.

Scientists at Case Western Reserve University (Cleveland, OH, USA) performed a comparative microbial analysis of paired amniotic fluid (AF) and cord blood (CB) from pregnancies complicated by preterm birth and early-onset neonatal sepsis. The biological samples from 44 women were collected from September 2004 to February 2009.

Amniotic fluid (AF) was cultured for aerobic and anaerobic bacteria, Ureaplasma and Mycoplasma species. DNA was extracted from AF or CB serum. To identify the species amplified by polymerase chain reaction (PCR) and to ensure that the PCR amplicons were indeed bacterial ribosomal ribonucleic acid (rRNA) genes rather than artifacts, the PCR products were cloned into the pCR8 vector (Invitrogen, Carlsbad, CA, USA).

The investigators found more than 20 bacterial species not discovered using standard culturing. Some of the uncultured species appeared in both the cord blood and amniotic fluid samples. The uncultured bacteria were detected with DNA genomic analysis that had been used in a prior study that discovered the link between oral bacteria that causes still- or premature-births due to infected amniotic fluid that is supposed to be a sterile environment.

Yiping Han, PhD, the professor of Periodontics and Reproductive Biology at the Case Western, said, "Culture independent technology has broadened our scope of understanding human pathogens. DNA testing techniques were able for the first time to detect the oral bacteria Fusobacterium nucleatum, Bergeyella, and Sneathia sanguinegens that brought on early neonatal sepsis and put newborns at risk of dying shortly after birth. Among these, F. nucleatum was found at the same high frequency as the well-known Escherichia coli, putting the former on the same importance scale as the latter." The study was published on February 20, 2013, in the journal Public Library of Science ONE.

Related Links:

Case Western Reserve University
Invitrogen



PURITAN MEDICAL
EUROIMMUN AG
Sekisui Diagnostics
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: Enzyme-linked immunosorbent kit (ELISA) specific for human copeptin (Photo courtesy of USCN Life Science).

Preeclampsia Biomarker Detected Very Early In Pregnancy

A biomarker has been discovered that could give expecting mothers and their doctors the first simple blood test to reliably predict that a pregnant woman may develop preeclampsia, at least as early as... Read more

Pathology

view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

Brain Tumor Chemotherapy Biomarkers Identified

Cancer researchers have identified a new biomarker that they believe can predict whether glioblastoma multiformes (GBMs), the most common and aggressive type of malignant brain tumor, will be susceptible... Read more

Lab Tech.

view channel
Image: The ADVIA Centaur XPT Immunoassay System delivers the results that clinicians depend upon for accurate diagnoses and better patient care (Photo courtesy of Siemens Healthcare).

Introduction of New Central Laboratory Clinical Analyzers Highlights Recent Lab Equipment Exposition

An impressive array of new automated analyzers for central diagnostic laboratories was unveiled at a recent lab equipment trade fair. The IFCC WorldLab exposition held June 22-26, 2014, in Istanbul... Read more

Industry News

view channel

EKF Wins Distribution Contract and Regulatory Approval for Target Regions

EKF Diagnostics Holdings (Cardiff, Wales, UK), an AIM-listed point-of-care, central laboratory and molecular diagnostics business, announced that it has signed a new distribution contract in China and that one of its OEM (original equipment manufacturer) partners has received further regulatory approval across several target... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.